Quality of life in adults with epilepsy is associated with anticonvulsant polypharmacy independent of seizure status

Polypharmacy was associated with worse QOL in patients with epilepsy despite seizure control. Further investigation into specific etiology of polypharmacy's influence on QOL is warranted in order to develop paradigms for optimal treatment.